The Mixed Hepatocellular-Cholangiocarcinoma Confirmed by Liver and Neck Node Biopsy

Mixed hepatocellular-cholangiocarcinoma accounts for about 1% of all hepatocellular carci- noma. In many cases, mixed hepatocellular-cholangiocarcinoma has been misdiagnosed as hepa- tocellular carcinoma or cholangiocarcinoma because of the indistinctive clinical course and radi- ologic findings. The clinical course and the pathologic characters are not known well, but it resem- bles the characteristics of hepatocellularcarcinoma rather than cholangiocarcinoma. So mixed hepa- tocellular-cholangiocarcinoma was classified as a kind of hepatocellular carcinoma. But the gr- owth and dissemination rate is faster than that of hepatocellular carcinoma and the prognosis more poor. So the exact diagnosis is important. Authors experienced a patient who has the mixed hepa- tocellular-cholangiocarcinoma diagnosed by liver and neck node biopsy in patient who complain-ed abdominal discomfort and palpable mass, so we report the case.